Point of Care Diagnostics Market to Reach $31.46 Billion by 2031, Driven by Rising Demand for Rapid and Decentralized Testing

Point of Care Diagnostics Market to Reach $31.46 Billion by 2031, Driven by Rising Demand for Rapid and Decentralized Testing

IRIS Kinetics Unveils Point-of-Care Kinetic Biosensing Platform

The IRIS TX-100 uses cartridge-based technology to measure up to 100 biomarkers in approximately 10 minutes. IRIS Kinetics announced the IRIS TX-100, a point-of-care diagnostic platform that brings the company’s multiplex, label-free binding kinetics technology out of the research lab and into clinical settings. The company unveiled the system at the Association for Diagnostics & Laboratory Medicine 2026 meeting in Anaheim, California. The platf…

IRIS Kinetics Announces Entry into Diagnostics with the IRIS TX-100, Bringing Lab-Grade Kinetic Biosensing to the Point of Care

IRIS Kinetics today announced the IRIS TX-100, a point-of-care diagnostic platform that brings the company's multiplex, label-free binding kinetics technology out of the research lab and into clinical settings.